Gene · 5281
Papers2,279
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,279
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role of Endocrine Disrupting Chemicals in Gestation and Pregnancy Outcomes. | Nutrients | 2023 | 37960310 | PubTator, text mining | PubMed |
| Impact of Endometrial Preparation on the Maternal and Fetal Cardiovascular Variables of the First Trimester Combined Screening Test. | J Clin Med | 2023 | 37959319 | PubTator, text mining | PubMed |
| Immunometabolic Profiling of Chronic Subdural Hematoma through Untargeted Mass Spectrometry Analysis: Preliminary Findings of a Novel Approach. | Diagnostics (Basel) | 2023 | 37958242 | PubTator, text mining | PubMed |
| Endometrial fluid biomarkers and their potential as predictors of successful embryo implantation. | Biomedicine (Taipei) | 2023 | 37937060 | PubTator, text mining | PubMed |
| Vascular normalization: reshaping the tumor microenvironment and augmenting antitumor immunity for ovarian cancer. | Front Immunol | 2023 | 37936692 | PubTator, text mining | PubMed |
| Krukenberg Tumor of Gastric Origin in Pregnant Women with Preeclampsia. | Case Rep Oncol | 2023 | 37936663 | PubTator, text mining | PubMed |
| Disease specific urinary biomarkers in the central nervous system. | Sci Rep | 2023 | 37935834 | PubTator, text mining | PubMed |
| Pathophysiological impact of CXC and CX3CL1 chemokines in preeclampsia and gestational diabetes mellitus. | Front Cell Dev Biol | 2023 | 37928902 | PubTator, text mining | PubMed |
| Methodology for Isolation of miRNA From the Serum of Women Investigated for Pre-eclampsia. | Cureus | 2023 | 37905272 | PubTator, text mining | PubMed |
| Tumor Angiocrine Signaling: Novel Targeting Opportunity in Cancer. | Cells | 2023 | 37887354 | PubTator, text mining | PubMed |
| Tumor heterogeneity and tumor-microglia interactions in primary and recurrent IDH1-mutant gliomas. | Cell Rep Med | 2023 | 37883975 | PubTator, text mining | PubMed |
Microinvasive pars plana vitrectomy combined with internal limiting membrane peeling versus anti-VEGF intravitreal injection for treatment-naïve diabetic macular edema (VVV-DME study): study protocol for a randomized controlled trial. | Trials | 2023 | 37875997 | PubTator, text mining | PubMed |
| Association of serum levels of vascular endothelial growth factor and placental growth factor in early threatened abortion and premature delivery: A case‑control study. | Exp Ther Med | 2023 | 37869637 | PubTator, text mining | PubMed |
| Antiangiogenic Action of JZL184 on Endothelial Cells via Inhibition of VEGF Expression in Hypoxic Lung Cancer Cells. | Cells | 2023 | 37830546 | PubTator, text mining | PubMed |
| Generation of 3D lung organoids from human induced pluripotent stem cells for modeling of lung development and viral infection. | Heliyon | 2023 | 37809493 | PubTator, text mining | PubMed |
| KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer. | Acta Pharm Sin B | 2023 | 37799381 | PubTator, text mining | PubMed |
| Advances in Screening for Radiation-Associated Cardiotoxicity in Cancer Patients. | Curr Cardiol Rep | 2023 | 37796395 | PubTator, text mining | PubMed |
| Panretinal photocoagulation plus intravitreal conbercept for diabetic retinopathy in real world: a retrospective study. | BMC Ophthalmol | 2023 | 37794367 | PubTator, text mining | PubMed |
| Causal association between placental growth factor and coronary heart disease: a Mendelian randomization study. | Aging (Albany NY) | 2023 | 37787982 | PubTator, text mining | PubMed |
| The emerging roles of metabolism in the crosstalk between breast cancer cells and tumor-associated macrophages. | Int J Biol Sci | 2023 | 37781517 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5281/papers?page=7